@Davisite Are you able to expand on what 'Completion of package of phase 3 readiness studies' entails. Is it just testing that the active ingredient meets FDA requirements for P3 trials?
Are you able to comment on how long Ardena will need to use this batch to complete RC220 formulation?
Glad RAC were able to once again reset the patent clock, the race is now on to get this ball rolling.
Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs, page-9
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.46 | $129.2K | 87.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7418 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 38353 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |